It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick ...
(RTTNews) - As per a report published in the Financial Times, Siemens Healthineers (SMMNY.PK) is planning to buy Advanced Accelerator Applications, a Novartis company, which is focused exclusively on ...
Hosted on MSN
Siemens Healthineers To Buy Novartis Diagnostics To Bolster Cancer Scan Business In $220M Deal
Siemens Healthineers agreed to acquire Novartis AG’s (NYSE:NVS) diagnostics arm for $223.5 million (200 million euros) in a deal meant to enhance its cancer treatments. Both companies confirmed the ...
SAINT-GENIS-POUILLY, France, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), a leader in nuclear medicine theragnostics, today announced ...
SAINT-GENIS-POUILLY, France, March 06, 2017 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or the “Company”), an international specialist in Molecular Nuclear Medicine ...
* ADVANCED ACCELERATOR APPLICATIONS - UNIT OF NOVARTIS COMMENCED CASH TENDER OFFER TO PURCHASE ALL OF CO'S ORDINARY SHARES FOR $41.00/SHARE, $82.00/ADS * ADVANCED ACCELERATOR APPLICATIONS SA - OFFER ...
Advanced Accelerator Applications S.A. ((AAAP)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and ...
Swiss pharmaceutical giant Novartis AG (NYSE:NVS) is reportedly contemplating selling sections of radiopharmaceuticals company Advanced Accelerator Applications to align with the company's strategy ...
Boardscategory Starbucks taps Chipotle's Niccol as CEO in surprise move, shares soar 2:47 PM UTC · Updated ago U.S. Marketscategory Cheaper services curb US producer price gains in July 2:18 PM UTC ...
Advanced Accelerator Applications (Nasdaq: AAAP), the French radiopharmaceutical and diagnostic products company whose acquisition by Novartis (NYSE: NVS) is through the tender process as of this week ...
Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Note: Hover over the donut graph to view ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback